| Bioactivity | COG1410 is an apolipoprotein E-derived peptide. COG1410 exerts neuroprotective and antiinflammatory effects in a murine model of traumatic brain injury (TBI). COG1410 can be used for the research of neurological disease[1][2]. | ||||||
| Invitro | COG1410 (1-25 μM; 48 h) decreases the production and release of NO and TNFα in BV2 microglia cells[1]. | ||||||
| Name | COG1410 | ||||||
| CAS | 878009-24-6 | ||||||
| Shortening | Ac-AS-{Aib}-LRKL-{Aib}-KRLL-NH2 | ||||||
| Formula | C64H121N21O14 | ||||||
| Molar Mass | 1408.78 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light, under nitrogen
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) |
COG1410
CAS: 878009-24-6 F: C64H121N21O14 W: 1408.78
COG1410 is an apolipoprotein E-derived peptide. COG1410 exerts neuroprotective and antiinflammatory effects in a murine
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.